The global allergy diagnostics market was valued at USD 4.58 billion in 2020 and growing at a CAGR of 11.78% during the forecast period (2022 to 2026); it is expected to reach USD 8.93 billion by 2026. Some of the key factors, such as the rapidly rising incidence of allergic diseases, increasing environmental pollution, technological advancements, and the launch of new allergy diagnostic tests catering to different types of allergies, are expected to drive the allergy diagnostics market growth in the coming years. Some of the key market players operating in the allergy diagnostics market include HOB Biotech Group Corp., Thermo Fisher Scientific, Siemens Healthineers, Danaher, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika, HollisterStier Allergy, Eurofins Scientific, Omega Diagnostics Group, HYCOR Biomedical, R-Biopharm AG, AEKSU GROUP GmbH, ACON Laboratories, Lincoln Diagnostics, Astra Biotech GmbH, Erba Group, Hitachi Chemical Diagnostic, Hemostasis Inc, BioMerieux SA, PerkinElmer Holdings Ltd, and others.
DelveInsight’s “Allergy Diagnostics Market Outlook 2026” research report provides the current and forecasted Allergy Diagnostics Market size, share, and trends analysis for the next five years, upcoming innovations in the segment, and major market drivers & barriers. The report also covers the key competitors and emerging devices in the domain.
Global Allergy Diagnostics: Overview
Allergy diagnostics is a broad term that encompasses various devices, instruments, kits, and services that help in identifying the reactive components that are responsible for the anaphylactic reactions in the body. To provide a better understanding of the evolving market dynamics, DelveInsight’s “Allergy Diagnostics Market” report provides an in-depth analysis of the market based on segmentation such as type (products [instruments and consumables], and services), allergy type (food allergy, drug allergy, inhalant allergy, and others), diagnostic test type (in-vivo and in-vitro), end-user (hospitals, diagnostic centers, and others), geography.
As per the assessment, in the allergy type segment of the allergy diagnostics market, the drug allergy category is estimated to hold a major market share in the allergy diagnostics market. The rising prevalence of adverse effects arising from different types of medications amongst individuals across the globe is one of the key factors attributing to the high growth of the drug allergy category. Moreover, several studies have stated that certain classes of drugs, such as antibiotics, are common triggers that trigger drug allergies in many patients. Therefore, in order to avoid adverse events associated with drug allergies, allergy diagnostics may play a key role in identifying potentially unsuitable drugs for patients, thereby helping caregivers and doctors devise alternative prognostic routes.
As per the estimate, the allergy diagnostics market is anticipated to grow in the coming years owing to the rising incidence of allergic diseases. Moreover, the deteriorating air quality (due to rapid urbanization) has led to a significant increase in the levels of air pollutants such as cigarette smoke, vehicular emission, dust particles, pollen, etc. is contributing to the growing cases of allergies associated with air pollution which in turn are leading to the market growth of allergy diagnostics. Air pollution is linked with the increased incidence of diseases such as allergic rhinitis, asthma, and other allergic disorders. Henceforth, the above-mentioned factors will contribute to the global allergy diagnostics market growth in the coming years.
However, some of the key aspects, such as the premium prices associated with allergy diagnostics instruments and lack of awareness about allergic diseases, may hinder the allergy diagnostics market growth in the coming years.
The allergy diagnostics market was negatively impacted by the precautionary measures taken by health agencies and governments worldwide to curb the spread of the COVID-19 infection. However, with the approval of numerous COVID-19 vaccines, improvement in vaccination, slower transmission rate, and a significant reduction in the Covid-19 related casualties, the allergic diagnostics market is expected to reach pre-COVID levels and exhibit high growth in the coming years.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight into Allergy Diagnostics Types and Emerging Products
According to DelveInsight’s assessment, among all the regions, North America is anticipated to hold a major share in the overall allergy diagnostics market in the coming years. This domination is primarily due to the increasing incidence of allergies in the region. For instance, according to the Asthma and Allergy Network Organization, in 2020, about 6.5% of children under 18 years of age suffered from food allergies in the United States. Moreover, approximately 9.6% of the country’s total population suffered from respiratory allergies. As per CDC, in 2020, the number of people diagnosed with hay fever in the United States was about 19.2 million.
The rising awareness regarding allergies of various etiologies, the presence of key market players in the region, and the well-established centers offering allergy & immunology services in the region are further expected to contribute to the high uptake of allergy diagnostic products in the region. Moreover, new product development, regulatory approvals, and strategic collaborations are also expected to boost the United States allergy diagnostics market in the coming years.
Overall, the growing number of allergy diseases such as food allergy, drug allergy, hay fever, and others, along with the rising number of manufacturers and product approvals, are observed to anticipate the demand for allergy diagnostics market in the United States, thereby increasing the overall allergy diagnostics market in the region.
Interested in knowing how the market will grow by 2026? Click to get a snapshot of Allergy Diagnostics Market Trends and Developments
Over the years, the allergy diagnostics market has evolved significantly owing to the active participation of global MedTech companies and technological advancements in the domain.
- In July 2021, IDS was acquired by PerkinElmer (UK) Holdings Limited, wherein the former has a product portfolio catering to allergy diagnostics.
- In July 2020, Thermo Fisher Scientific received regulatory approval from the US FDA for their ImmunoCAP Specific IgE alpha-Gel Allergen Component test for in-vitro use.
- In April 2019, Bluejay Diagnostics received the CE mark approval for their allergic conjunctivitis test- Allereye Tear Total IgE Test, a non-invasive, point-of-care (POC) test for allergic conjunctivitis.
As per DelveInsight, the ongoing clinical & commercial development activities and research in the domain will contribute immensely to the allergy diagnostics market in the coming years.
Globally, some of the leading companies in the allergy diagnostics market include HOB Biotech Group Corp., Thermo Fisher Scientific, Siemens Healthineers, Danaher, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika, HollisterStier Allergy, Eurofins Scientific, Omega Diagnostics Group, HYCOR Biomedical, R-Biopharm AG, AEKSU GROUP GmbH, ACON Laboratories, Lincoln Diagnostics, Astra Biotech GmbH, Erba Group, Hitachi Chemical Diagnostic, Hemostasis Inc, BioMerieux SA, PerkinElmer Holdings Ltd, and others.
As per DelveInsight, due to the very high growth rate and positive return, several new players are expected to enter the allergy diagnostics market in the coming years. The entry of new players and the launch of emerging products will immensely drive market growth.
Learn how new players’ entries will transform the market dynamics in the coming years at Allergy Diagnostics’ Competitive Landscape
Scope of the Allergy Diagnostics Market Report:
- Study Period – 2019-2026
- Geography Covered – Global (North America, Europe, Asia-Pacific, and Rest of the World)
- Allergy Diagnostics Market By Type – Products (Instruments And Consumables), and Services
- Allergy Diagnostics Market By Allergy Type – Food Allergy, Drug Allergy, Inhalant Allergy, and others
- Allergy Diagnostics Market By Diagnostic Test Type – In-Vivo and In-Vitro
- Allergy Diagnostics Market By End User – Hospitals, Diagnostic Centers, and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Table of Content
|Regulatory and Patent Analysis
|Allergy Diagnostics Market Key factors analysis
|Allergy Diagnostics Porter’s Five Forces Analysis
|COVID-19 Impact Analysis on Allergy Diagnostics Market
|Allergy Diagnostics Market Layout
|Allergy Diagnostics – Global Company Share Analysis – Key 3-5 Companies
|Allergy Diagnostics Product Profiles and Key Companies
Reach out to us to get a more detailed overview of the Allergy Diagnostics Regulatory & Patent Analysis
Related Healthcare Reports by DelveInsight
“Food Allergy Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, Canada, and China. Some of the key companies in the Food Allergy Market include Novartis, DBV Technologies, InnoUp Farma, Genentech, Rho Federal Systems Division, and others.
“Food Allergy Epidemiology Forecast 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology of Food Allergy in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Canada, and China.
“Food Allergy Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in the Food Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products.
Global in vitro diagnostics market was valued at USD 71.01 billion in 2021, growing at a CAGR of 4.71% during the forecast period from 2022 to 2027; in order to reach USD 93.60 billion by 2027. Some of the key companies in the market include F. Hoffmann-La Roche Ltd, Abbott, FUJIFILM Corporation, Sysmex, Siemens Healthcare, BD, Seegene, Beckman Coulter, QIAGEN, bioMérieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific, Cisbio (PerkinEemer), ARKRAY, Ortho Clinical Diagnostics, ACON Laboratories, Teco Diagnostics, EKF Diagnostics, Besurence, Savyon Diagnostics, HORIBA, Palliance AB, Sugentech, Cypress Diagnostics, Salignostics, Menarini Group, DxGen, HUMAN, Nova Biomedical, Asahi Kasei Pharma Corporation, Agilent Technologies, and several others.
“Asthma Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology of asthma and the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. Some of the key companies in the Asthma Market include Aquilon Pharma, 4D Pharma PLC, GlaxoSmithKline, Jiangsu Hengrui Medicine, AstraZeneca, Oneness Biotech, and others.
“Peanut Allergy Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology of Peanut Allergy and the market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the key companies in the Peanut Allergy Market include Nestle Health Sciences, DBV Technologies, Regeneron/Sanofi, Camallergy, Vedanta Biosciences, Alladapt Immunotherapeutics, InnoUp Farma, COUR Pharmaceuticals, Novartis/Genentech, and others.
Latest Healthcare Blog by DelveInsight
- Top 9 Most Common Food Allergies
- Peanut Allergy Market Outlook: The Market Size Growth Sees Major Thrusts
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Learn How the MedTech Devices Market is evolving with the ongoing clinical and commercial developments in the domain: MedTech and Diagnostics Market Assessment